Investors & Media

SEC Filing Details

Investor Relations Menu
Investor Home
News & Events
Press Releases Events & Presentations
Stock Information
Stock Quote & Chart Historic Price Lookup Investment Calculator Analyst Coverage
Financials & Filings
SEC Filings
Corporate Governance
Documents & Charters Management Team Board of Directors Scientific Advisory Board Committee Composition
Investor Resources
Investor FAQs Investor Contact Email Alerts
Contact

Elizabeth Pingpank Hickin
Vice President, Investor Relations
ehickin@zentalis.com

Document Details

Form
144
Filing Date
Oct 4, 2023
Document Date
Oct 4, 2023
Form Description
Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing
Filing Group
Other
Company
Zentalis Pharmaceuticals
Issuer
ZENTALIS PHARMACEUTICALS, INC.

Filing Formats

View HTML
Download PDF
Download DOC